Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;97(1):104-113.
doi: 10.1038/labinvest.2016.115. Epub 2016 Nov 21.

Covalently deposited dyes: a new chromogen paradigm that facilitates analysis of multiple biomarkers in situ

Affiliations
Free article

Covalently deposited dyes: a new chromogen paradigm that facilitates analysis of multiple biomarkers in situ

William A Day et al. Lab Invest. 2017 Jan.
Free article

Abstract

Multiplexed analysis of multiple biomarkers in a tissue sample requires use of reporter dyes with specific spectral properties that enable discrimination of signals. Conventional chromogens with broad absorbance spectra, widely used in immunohistochemistry (IHC), offer limited utility for multiplexed detection. Many dyes with narrow absorbance spectra, eg rhodamines, fluoresceins, and cyanines, potentially useful for multiplexed detection are well-characterized; however, generation of a chromogenic reagent useful for IHC analysis has not been demonstrated. Studies reported herein demonstrate utility of tyramine-chemistry for synthesis of a wide variety of new chromogenic dye conjugates useful for multiplexed in situ analysis using conventional light microscopes. The dyes, useful individually or in blends to generate new colors, provide signal sensitivity and dynamic range similar to conventional DAB chromogen, while enabling analysis of co-localized biomarkers. It is anticipated that this new paradigm will enable generation of a wide variety of new chromogens, useful for both research and clinical biomarker analysis that will benefit clinicians and patients.

PubMed Disclaimer

References

    1. J Immunol Methods. 1991 Mar 1;137(1):103-12 - PubMed
    1. J Histochem Cytochem. 1966 Dec;14(12):929-31 - PubMed
    1. J Immunol Methods. 1989 Dec 20;125(1-2):279-85 - PubMed
    1. Diagn Pathol. 2014 Jul 21;9:144 - PubMed
    1. Cytometry. 1996 Jan 1;23(1):48-53 - PubMed

MeSH terms